Posted on 2/17/21
Cedar Partners With Summit CityMD to Offer a New, Patient-Forward Financial Experience
Cedar's end-to-end patient engagement platform will give millions of patients across New York and New Jersey a consumer-centric digital experience at every step of the revenue . . .
Posted on 2/17/21
Royalty Pharma Reports Q4 2020 and Full-Year Results
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the fourth quarter of 2020 and introduced full-year . . .
Posted on 2/17/21
Statewide COVID Vaccine Registration Site Launched
The Virginia Department of Health launched its COVID-19 vaccine registration system Tuesday, available at vaccinate.virginia.gov. A phone hotline will open Wednesday, allowing Virginians who don’t have . . .
Posted on 2/17/21
In-Q-Tel Joins $17 Million for ImmuneID
ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, announced a $17M financing led
Posted on 2/17/21
ImmuneID Launches with $17M Financing
ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, announced a $17M financing led
Posted on 2/17/21
Charles River Laboratories to Acquire Cognate BioServices for $875 Million
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has signed a definitive agreement to acquire Cognate BioServices, Inc., a premier, cell and gene . . .
Posted on 2/17/21
Moderna Hits a Short-Term Vaccine Manufacturing Delay, Still on Track for First 100 Million Doses by End of March
Moderna (NASDAQ:MRNA) has hit a bit of a snag with the manufacturing of its COVID-19 vaccine. The company's fill-and-finish contractor, Catalent (NYSE:CTLT), is experiencing delays with . . .
Posted on 2/17/21
Pattern Health Secures $1.5M
Pattern Health, a Durham, N.C.-based digital health company, raised $1.5m in funding.
Posted on 2/16/21
Onconova Therapeutics Closes $28.75M Public Offering of Common Stock
NEWTOWN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat . . .
Posted on 2/16/21
KalVista Pharmaceuticals Closes its Upsized Public Offering of Common Stock
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the closing of its previously announced upsized public offering of 6,181,250 shares of its . . .
Posted on 2/16/21
Maryland Reports 516 New Cases, Marking Smallest Daily Total Since October
Maryland health officials on Tuesday reported 516 new cases of coronavirus, the lowest number of daily new cases reported since the state confirmed 492 cases on . . .
Posted on 2/16/21
Galmed Pharmaceuticals Prices of $10 Million Public Offering of Ordinary Shares
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced the pricing of the underwritten public offering of 2,197,803 . . .
Posted on 2/16/21
Pulmatrix Closes of $40 Million Registered Direct Offering
Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE technology, today . . .
Posted on 2/16/21
CVS Health Reports Fourth Quarter And Full-Year 2020 Results
WOONSOCKET, R.I., Feb. 16, 2021 /PRNewswire/ -- Full Year and Fourth Quarter Highlights: Full year total revenues increased to $268.7 billion, up 4.6% compared to prior year . . .
Posted on 2/16/21
Zoetis Reports Fourth Quarter and Full Year 2020 Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2020 and provided full year guidance for 2021.The . . .
Posted on 2/16/21
IQVIA Offers of Senior Notes
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc., intends to raise €1,450,000,000 in gross proceeds . . .
Posted on 2/16/21
Centessa Pharmaceuticals Launches with $250 Million Series A Financing
Centessa Pharmaceuticals launched today as a novel asset-centric pharmaceutical company designed and built to advance a portfolio of highly validated programs. Centessa’s asset-centric
Posted on 2/16/21
Guided Therapeutics Raises US $1.1 Million in New Preferred Stock Offering
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that . . .
Posted on 2/16/21
SunLink Health Systems Announces Fiscal 2021 Second Quarter Results
ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $3,146,000 ($0.46 per fully diluted share) for its second fiscal quarter . . .
Posted on 2/16/21
The CM Group Acquires Scientific Commercialization
The CM Group, LLC, a leading provider of information and knowledge services to the biopharmaceutical community, announces the acquisition of Scientific Commercialization, LLC
Posted on 2/16/21
Outlook Therapeutics Reports Financial Results for First Quarter Fiscal Year 2021 and Provides Corporate Update
MONMOUTH JUNCTION, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic . . .
Posted on 2/16/21
GBS Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients . . .
Posted on 2/16/21
Teleflex Named One of America’s Best Employers 2021 by Forbes
WAYNE, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), has been recognized as part of Forbes’ list of America’s Best Employers 2021. The . . .
Posted on 2/16/21
Hepion Pharmaceuticals Prices of Public Offering
EDISON, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the . . .
Posted on 2/16/21
Baudax Bio Reports 2020 Annual Financial Results
MALVERN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today reported its . . .
